Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes

The summary for the Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes: The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to assess the long-term effectiveness, cost-effectiveness, and barriers to enrollment in or completion of structured lifestyle interventions (SLI), as implemented by the National Diabetes Prevention Program (NDPP). This NOFO has two (2) components to achieve the purpose of the program: Component A: To evaluate the long-term (≥5 years) effectiveness and cost-effectiveness of SLI participants, and identify barriers to participation and adherence in these SLI programs, overall and by age group, sex, race/ethnicity, and socio-economic status. The study participants are those who meet the NDPP eligibility criteria and completed the NDPP curriculum. The study will also include a control group consisting of individuals who meet the NDPP eligibility criteria but are either not enrolled in the SLI program or do not complete it. Applicants shall connect individual level data from SLI program providers, electronic health records and claims with follow up information on the study participants for a minimum of 5 years. The study shall include SLI delivered in person, virtually, and a combination of the two. Component B: The Coordinating Center provides the infrastructure for data storage (if needed), harmonizing data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.

Federal Grant Title:	Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DP-22-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.068
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 1st, 2022
Original Application Deadline:	February 1st, 2022
Posted Date:	November 18th, 2021
Creation Date:	November 18th, 2021
Archive Date:	March 3rd, 2022
Total Program Funding:	$16,000,000
Maximum Federal Grant Award:	$570,000
Minimum Federal Grant Award:	$0
Expected Number of Awards:	6
Cost Sharing or Matching:	No
Last Updated:	January 27th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.) - Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: For an applicant to be even considered they must be responsive to the following. Component A - Longitudinal Cohort: Applicants must provide evidence of being able to access electronic records for building a cohort of individuals meeting eligibility criteria for the NDPP/MDPP (both participated in the NDPP/MDPP and not participated but eligible for the NDPP/MDPP program), individual program participation information of the NDPP/MDPP participants, medical records and health services utilization and cost data of all study participants. A minimum number of 5,000 NDPP/MDPP program enrollees and equal or a greater number of matched controls is required per applicant. If the application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component B - Coordinating Center: Not Applicable
Grant Announcement Contact: Dionne Godette-Greer, PhD
[email protected]
[email protected]
Similar Government Grants: • Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations ...; • PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determi...; • PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Diabetes Prevention and Control in the Americas; • Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease ...; • Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth ...
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...